The widening landscape of synthetic incretin treatment: possible association of ischaemic optic neuropathy risk and the need for a cautious approach.
作者信息
Varughese Maria S, Kalidindi Sushuma
机构信息
University of Sheffield, School of Medicine and Population Health, Sheffield, South Yorkshire, UK.
Department of Diabetes & Endocrinology, University Hospitals of North Midlands NHS Trust, Sheffield, UK.
出版信息
Eye (Lond). 2025 Jun;39(8):1648-1649. doi: 10.1038/s41433-025-03776-4. Epub 2025 Apr 3.
Abstract
摘要
相似文献
1
The widening landscape of synthetic incretin treatment: possible association of ischaemic optic neuropathy risk and the need for a cautious approach.
Eye (Lond). 2025 Jun;39(8):1648-1649. doi: 10.1038/s41433-025-03776-4. Epub 2025 Apr 3.
3
Surgery for nonarteritic anterior ischemic optic neuropathy.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD001538. doi: 10.1002/14651858.CD001538.pub3.
4
Surgical orbital decompression for thyroid eye disease.
Cochrane Database Syst Rev. 2011 Dec 7(12):CD007630. doi: 10.1002/14651858.CD007630.pub2.
5
Cell-based therapies for traumatic optic neuropathy: Recent advances, challenges, and perspectives.
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01322.
7
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296.
8
Surgery for nonarteritic anterior ischemic optic neuropathy.
Cochrane Database Syst Rev. 2000(2):CD001538. doi: 10.1002/14651858.CD001538.
9
Diagnostic Role of Tissue Biopsy in Leukemic or Lymphomatous Infiltrative Optic Neuropathy: A Case Report and Systematic Review of Literature.
Ophthalmic Plast Reconstr Surg. 2025;41(4):388-395. doi: 10.1097/IOP.0000000000002876. Epub 2025 Jan 16.
10
A case-control study of peripapillary microvascular structure by OCT-angiography in non-arteritic ischaemic optic neuropathy at early and resolutive stages.
Eye (Lond). 2025 Mar;39(4):771-778. doi: 10.1038/s41433-024-03439-w. Epub 2024 Nov 22.
引用本文的文献
1
Hybrid closed loop and intensive insulin delivery technology: Reviewing the effect of improving 'time in range' glucose levels on diabetic retinopathy.
Eye (Lond). 2025 Apr;39(6):1028-1030. doi: 10.1038/s41433-025-03730-4. Epub 2025 Feb 20.
本文引用的文献
1
Are synthetic incretins associated with ischaemic optic neuropathy?
Eye (Lond). 2025 Apr;39(5):808-809. doi: 10.1038/s41433-025-03718-0. Epub 2025 Feb 15.
2
Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.
Endocrinol Diabetes Metab. 2025 Mar;8(2):e70019. doi: 10.1002/edm2.70019.
3
Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes.
JAMA Intern Med. 2025 Apr 1;185(4):399-410. doi: 10.1001/jamainternmed.2024.7811.
4
Semaglutide: Nonarteritic Anterior Ischemic Optic Neuropathy in the FDA adverse event reporting system - A disproportionality analysis.
Obes Res Clin Pract. 2025 Jan-Feb;19(1):77-79. doi: 10.1016/j.orcp.2025.01.011. Epub 2025 Feb 7.
5
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks.
Front Clin Diabetes Healthc. 2025 Jan 9;5:1530811. doi: 10.3389/fcdhc.2024.1530811. eCollection 2024.
Zotero 插件